- Home
- NVCT vs DYNX Comparison
NVCT vs DYNX Comparison
Compare NVCT & DYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- DYNX
- Stock Information
- Founded
- NVCT 2020
- DYNX 2024
- Country
- NVCT United States
- DYNX United States
- Employees
- NVCT N/A
- DYNX N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- DYNX
- Sector
- NVCT Health Care
- DYNX
- Exchange
- NVCT Nasdaq
- DYNX NYSE
- Market Cap
- NVCT 184.9M
- DYNX 221.3M
- IPO Year
- NVCT 2022
- DYNX 2024
- Fundamental
- Price
- NVCT $7.26
- DYNX $10.19
- Analyst Decision
- NVCT Strong Buy
- DYNX
- Analyst Count
- NVCT 3
- DYNX 0
- Target Price
- NVCT $17.00
- DYNX N/A
- AVG Volume (30 Days)
- NVCT 186.4K
- DYNX 14.9K
- Earning Date
- NVCT 08-05-2025
- DYNX 01-01-0001
- Dividend Yield
- NVCT N/A
- DYNX N/A
- EPS Growth
- NVCT N/A
- DYNX N/A
- EPS
- NVCT N/A
- DYNX N/A
- Revenue
- NVCT N/A
- DYNX N/A
- Revenue This Year
- NVCT N/A
- DYNX N/A
- Revenue Next Year
- NVCT N/A
- DYNX N/A
- P/E Ratio
- NVCT N/A
- DYNX N/A
- Revenue Growth
- NVCT N/A
- DYNX N/A
- 52 Week Low
- NVCT $4.44
- DYNX $9.78
- 52 Week High
- NVCT $11.80
- DYNX $10.48
- Technical
- Relative Strength Index (RSI)
- NVCT 29.72
- DYNX N/A
- Support Level
- NVCT $7.84
- DYNX N/A
- Resistance Level
- NVCT $8.27
- DYNX N/A
- Average True Range (ATR)
- NVCT 0.45
- DYNX 0.00
- MACD
- NVCT -0.08
- DYNX 0.00
- Stochastic Oscillator
- NVCT 6.12
- DYNX 0.00
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About DYNX DYNAMIX CORP
Dynamix Corp is a blank check company.